Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Atomoxetine hydrochloride - Generic Drug Details

« Back to Dashboard
Atomoxetine hydrochloride is the generic ingredient in two branded drugs marketed by Lilly and Zydus Pharms Usa Inc, and is included in two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for atomoxetine hydrochloride. Seven suppliers are listed for this compound. There are seven tentative approvals for this compound.

Summary for Generic Name: atomoxetine hydrochloride

Drug Master File Entries: see list14
Suppliers / Packagers: see list7
Bulk Api Vendors: see list42
Clinical Trials: see list1,012
Patent Applications: see list1,043
Therapeutic Class:Central Nervous System Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:atomoxetine hydrochloride at DailyMed

Pharmacology for Ingredient: atomoxetine hydrochloride


Applicant Application No. Form Dosage
<disabled><disabled>CAPSULE; ORAL10MG
<disabled><disabled>CAPSULE; ORAL100MG
<disabled><disabled>CAPSULE; ORAL18MG
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
atomoxetine hydrochloride
CAPSULE;ORAL021411-004Nov 26, 2002RXYesNo5,658,590*PED► subscribeY► subscribe
Zydus Pharms Usa Inc
atomoxetine hydrochloride
CAPSULE;ORAL079017-004Sep 17, 2010DISCNNoNo► subscribe► subscribe
Zydus Pharms Usa Inc
atomoxetine hydrochloride
CAPSULE;ORAL079017-003Sep 17, 2010DISCNNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.